In recent years, artificial intelligence technology has received much attention and is known as one of the key words in China's technological development. It is rapidly being applied to various aspects of industrial development and social life.

On March 24th, during the 16th China Interventional Cardiology Conference (CIT), Lepu (Beijing) Medical Equipment Co., Ltd. (hereinafter referred to as "Lepu Medical"), a large health platform enterprise focusing on the "entire ecosystem of cardiovascular disease" in China, released its independently developed "AI-ECG Platform ECG Artificial Intelligence Automatic Analysis and Diagnosis System", marking the official launch of the first AI ECG automatic analysis and diagnosis system in China!

Domestic cardiovascular experts, including academicians of the CAE Member, Professor Han Yaling of the General Hospital of Shenyang Military Region, Professor Ma Changsheng of Anzhen Hospital, and Professor Pan Xiangbin of Fuwai Hospital, have given full recognition and expectation to the AI-ECG Platform System. At present, this product has been accepted by FDA.